Protective mechanism of rosiglitazone on renal injury of severe acute pancreatitis
Shao-liang WANG,Wei-xing WANG,Jian-hua YU,You-ming XU,Chen CHEN,Shu-long WANG,Jia YU,Xiao-yan CHEN
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2012.05.043
2012-01-01
Abstract:Objective To investigate the protective mechanism of rosiglitazone,the highly selective peroxisome proliferator activated receptor-γ (PPAR-γ) agonist,on renal injury of rats with severe acute pancreatitis (SAP).Methods Fifty-four male Wistar rats were randomly divided into three groups:sham operation group (SO group),SAP group and rosiglitazone pretreatment group (ROSI group).Acute pancreatitis model was induced by retrograde infusion of 5％ sodium taurocholate into the biliopancreatic duct.Rosiglitazone (6 mg/kg) dissolved in 10％ DMSO were injected through the femoral vein 30 min piror to the operation.The rats in SO group and SAP group were injected partes aequales 10％ DMSO.Rats were sacrificed at 3,12 and 24 h after operation,then the contents of nitric oxide (NO) and inducible nitric oxide synthase (iNOS),the levels of nuclear factor-κB (NF-κB)/p65,and tumor necrosis factor (TNF)-α and intercellular adhesion molecule-1 (ICAM-1) mRNA/proteins of kidney tissue samples were measured and analyzed statistically.Results At 3,12 and 24 h after operation in SAP group,the contents of NO was (2.34 ±0.31),(7.73 ±0.48),(17.33 ±0.89) mg/g; the levels of NF-κB/p65 was (30 648.11 ± 2655.13 ),( 53 654.63 ± 3065.94 ),( 70 546.85 ± 5046.55 ) ; the level of TNF-α was 4.18 ± 0.61,5.69 ± 0.82,11.86 ± 2.49 ; the level of ICAM-1 was 3.68 ± 0.58,6.48 ± 0.76,8.62 ±1.09,respectively,all were significantly increased (P ＜ 0.05 ) aas compared with SO group.In ROSI group,the contents of NO at 12 and 24 h were (4.10 ±0.62) and (6.09 ±0.79) mg/g; the level of NF-κB/p65 at 24 h was 30468.48 ± 2684.59 ; the level of TNF-α at 24 h was 6.60 ± 1.34 ; the level of ICAM-1 at 24 h was 2.92 ± 0.88,which were significantly reduced as compared with SAP group ( P ＜0.05).Conclusion Rosiglitazone protects rats with SAP from renal injury with the mechanisms involving inhibiting NF-κB and then inhibiting TNF-α and ICAM-1 production,thereby repressing the development of inflammation.